 |
fosbretabulin tromethamine |
|---|---|
| Trade Name | |
| Orphan Indication | Glioma |
| USA Market Approval | USA |
| USA Designation Date | 2016-06-08 00:00:00 |
| Sponsor | Mateon Therapeutics, Inc.;701 Gateway Boulevard, Suite 210;South San Francisco, California, 94080 |
Related Access Program